_pmid,_doi,_publicationTitle,_year,_confidence,_toolType,resourceName,resourceType,rrid,synonyms,description,aiSummary,howToAcquire,_resourceName
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,0.95,animal_model,129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- mice,Animal Model,,,,,,129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- mice
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,0.95,cell_line,NPcis cell line,Cell Line,,,,,,NPcis cell line
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model,Nf1 flox/flox ; Hoxb7-Cre mice,Animal Model,,,,,,Nf1 flox/flox ; Hoxb7-Cre mice
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model,Nf1 f/neo ; hGFAP-Cre mice,Animal Model,,,,,,Nf1 f/neo ; hGFAP-Cre mice
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line,BJFF.6,Cell Line,,,,,,BJFF.6
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line,Normal human Schwann cells (Sciencell),Cell Line,,,,,,Normal human Schwann cells (Sciencell)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,0.85,cell_line,TOP-10F' cells,Cell Line,,,,,,TOP-10F' cells
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,0.85,animal_model,DhhCre,Animal Model,,,,,,DhhCre
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.9,cell_line,MCF7,Cell Line,,,,,,MCF7
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.85,animal_model,2.3-kb α1(I) collagen-cre Nf1 flox/flox mice,Animal Model,,,,,,2.3-kb α1(I) collagen-cre Nf1 flox/flox mice
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.85,animal_model,Nf1 flox/flox mice,Animal Model,,,,,,Nf1 flox/flox mice
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.8,cell_line,Nf1 flox/flox calvaria osteoblasts,Cell Line,,,,,,Nf1 flox/flox calvaria osteoblasts
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line,DH10Bac cells,Cell Line,,,,,,DH10Bac cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line,BL21(DE3),Cell Line,,,,,,BL21(DE3)
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line,Sf9 cells,Cell Line,,,,,,Sf9 cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line,Tni-FNL cells,Cell Line,,,,,,Tni-FNL cells
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.95,cell_line,NF1-null HEK293T cell line,Cell Line,,,,,,NF1-null HEK293T cell line
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line,HEK293T,Cell Line,,,,,,HEK293T
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,0.95,animal_model,Nf1 flox,Animal Model,,,,,,Nf1 flox
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.95,cell_line,S462TY,Cell Line,,,,,,S462TY
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.9,cell_line,iSC,Cell Line,,,,,,iSC
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line,A549,Cell Line,,,,,,A549
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line,MCF10A,Cell Line,,,,,,MCF10A
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,0.95,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,0.95,clinical_assessment_tool,cNF-Skindex,Clinical Assessment Tool,,,,,,cNF-Skindex
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,0.9,cell_line,murine NF2 −/− Schwann cell line,Cell Line,,,,,,murine NF2 −/− Schwann cell line
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,0.9,cell_line,HEI-193,Cell Line,,,,,,HEI-193
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line,ipNF05.5 (mixed clone),Cell Line,,,,,,ipNF05.5 (mixed clone)
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line,ipNF05.5 (single clone),Cell Line,,,,,,ipNF05.5 (single clone)
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line,ipNF95.11bC,Cell Line,,,,,,ipNF95.11bC
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line,ipNF95.6,Cell Line,,,,,,ipNF95.6
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line,ipnNF95.11c,Cell Line,,,,,,ipnNF95.11c
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.9,animal_model,y w Mer4,Animal Model,,,,,,y w Mer4
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.85,animal_model,4/FM7; T80-Gal4 y w Mer4,Animal Model,,,,,,4/FM7; T80-Gal4 y w Mer4
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,0.95,animal_model,PLP CreERT2; Nf1 f/−; ROSA-LacZ mice,Animal Model,,,,,,PLP CreERT2; Nf1 f/−; ROSA-LacZ mice
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,0.85,animal_model,Nf1flox mice,Animal Model,,,,,,Nf1flox mice
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,0.9,animal_model,Nf1flox/flox,Animal Model,,,,,,Nf1flox/flox
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,0.9,animal_model,Nf1GFAP CKO,Animal Model,,,,,,Nf1GFAP CKO
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,0.9,cell_line,HEK-293T cells,Cell Line,,,,,,HEK-293T cells
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,0.9,cell_line,HEK 293T,Cell Line,,,,,,HEK 293T
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.9,cell_line,HEK 293T,Cell Line,,,,,,HEK 293T
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.9,cell_line,COS-7,Cell Line,,,,,,COS-7
PMID:23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,,0.9,animal_model,Nf1 +/− GFAP CKO,Animal Model,,,,,,Nf1 +/− GFAP CKO
PMID:23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,,0.9,animal_model,Nf1 flox/flox,Animal Model,,,,,,Nf1 flox/flox
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,0.95,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,0.9,cell_line,Nf1-/- mouse embryo fibroblasts,Cell Line,,,,,,Nf1-/- mouse embryo fibroblasts
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,0.9,cell_line,Nf1+/- mouse embryo fibroblasts,Cell Line,,,,,,Nf1+/- mouse embryo fibroblasts
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,0.9,cell_line,T265-2c,Cell Line,,,,,,T265-2c
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,0.9,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,0.9,cell_line,90-8,Cell Line,,,,,,90-8
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,0.95,animal_model,Nf1(flox/-);Col2.3Cre(+) mice,Animal Model,,,,,,Nf1(flox/-);Col2.3Cre(+) mice
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,0.9,animal_model,Nf1 +/− mice,Animal Model,,,,,,Nf1 +/− mice
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,0.9,animal_model,Nf1 flox/flox mice,Animal Model,,,,,,Nf1 flox/flox mice
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,0.9,cell_line,NF96.2,Cell Line,,,,,,NF96.2
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,0.9,cell_line,NF02.2,Cell Line,,,,,,NF02.2
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,0.9,cell_line,NF94.3,Cell Line,,,,,,NF94.3
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,0.95,cell_line,HEK293 cells,Cell Line,,,,,,HEK293 cells
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,0.85,cell_line,LLC-PK1 ATCC CL-101,Cell Line,,,,,,LLC-PK1 ATCC CL-101
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,0.9,cell_line,HEK 293T,Cell Line,,,,,,HEK 293T
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line,MIAPaCa-2,Cell Line,,,,,,MIAPaCa-2
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line,Panc-1,Cell Line,,,,,,Panc-1
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line,BxPC-3,Cell Line,,,,,,BxPC-3
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line,AsPC-1,Cell Line,,,,,,AsPC-1
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line,HPDE H6c7,Cell Line,,,,,,HPDE H6c7
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.9,cell_line,Ben-Men-1,Cell Line,,,,,,Ben-Men-1
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line,AC-CRISPR,Cell Line,,,,,,AC-CRISPR
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line,MN1-LF,Cell Line,,,,,,MN1-LF
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.8,cell_line,H358 cells,Cell Line,,,,,,H358 cells
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.9,cell_line,S462 cells,Cell Line,,,,,,S462 cells
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.9,cell_line,cis MPNST cell line,Cell Line,,,,,,cis MPNST cell line
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.9,cell_line,HTS-Luc MPNST cell line,Cell Line,,,,,,HTS-Luc MPNST cell line
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,pNF9511bc,Cell Line,,,,,,pNF9511bc
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,ipNF03.3,Cell Line,,,,,,ipNF03.3
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,ipn023λ,Cell Line,,,,,,ipn023λ
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.95,cell_line,S462,Cell Line,,,,,,S462
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,RHT92,Cell Line,,,,,,RHT92
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,LN229,Cell Line,,,,,,LN229
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.85,cell_line,2V6.11,Cell Line,,,,,,2V6.11
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,FiPS,Cell Line,,,,,,FiPS
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12",Cell Line,,,,,,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12"
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line,3PNF_SiPSsv_MM_11,Cell Line,,,,,,3PNF_SiPSsv_MM_11
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,patient_derived_model,JH-2-002,Patient-Derived Model,,,,,,JH-2-002
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,patient_derived_model,JH-2-031,Patient-Derived Model,,,,,,JH-2-031
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M724,Cell Line,,,,,,M724
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,SNF96.2,Cell Line,,,,,,SNF96.2
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.9,cell_line,HEK-293T,Cell Line,,,,,,HEK-293T
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M1,Cell Line,,,,,,M1
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M3,Cell Line,,,,,,M3
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M4,Cell Line,,,,,,M4
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M5,Cell Line,,,,,,M5
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line,M6,Cell Line,,,,,,M6
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,0.95,computational_tool,DINs (Deep Interactive Networks),Computational Tool,,,,,,DINs (Deep Interactive Networks)
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line,Drosophila Schneider (S2R+) cells,Cell Line,,,,,,Drosophila Schneider (S2R+) cells
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line,dNF1‐KO,Cell Line,,,,,,dNF1‐KO
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line,hTERT ipn02.3 2λ CRL‐3392,Cell Line,,,,,,hTERT ipn02.3 2λ CRL‐3392
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line,"ipnNF95.11C (hTERT NF1 ipnNF95.11c, RRID: CVCL_UI69)",Cell Line,,,,,,"ipnNF95.11C (hTERT NF1 ipnNF95.11c, RRID: CVCL_UI69)"
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line,"ipNF95.11b 'C' (hTERT NF1 ipNF95.11b C, RRID: CVCL_UI67)",Cell Line,,,,,,"ipNF95.11b 'C' (hTERT NF1 ipNF95.11b C, RRID: CVCL_UI67)"
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line,"ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)",Cell Line,,,,,,"ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)"
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",Cell Line,,,,,,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)"
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line,ST88‐14 (RRID: CVCL_8916),Cell Line,,,,,,ST88‐14 (RRID: CVCL_8916)
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,animal_model,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,Animal Model,,,,,,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,0.85,cell_line,U2OS,Cell Line,,,,,,U2OS
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,0.85,cell_line,HEK293,Cell Line,,,,,,HEK293
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,0.95,cell_line,HEI-193,Cell Line,,,,,,HEI-193
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,0.95,animal_model,"Trp53, Nf1, Suz12 triple mutant mice",Animal Model,,,,,,"Trp53, Nf1, Suz12 triple mutant mice"
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.85,cell_line,Human meningeal cells (HMC),Cell Line,,,,,,Human meningeal cells (HMC)
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.9,cell_line,Ben-Men-1 cells,Cell Line,,,,,,Ben-Men-1 cells
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,0.95,animal_model,Nf1Prx1-/-,Animal Model,,,,,,Nf1Prx1-/-
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,0.9,animal_model,Nf1flox/flox,Animal Model,,,,,,Nf1flox/flox
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,0.95,animal_model,Nf1 (+/-) mice,Animal Model,,,,,,Nf1 (+/-) mice
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,0.85,cell_line,lymphoblastoid cell lines,Cell Line,,,,,,lymphoblastoid cell lines
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,0.95,animal_model,Nf1flox/flox;PostnCre mice,Animal Model,,,,,,Nf1flox/flox;PostnCre mice
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,0.9,cell_line,iPNF95.6,Cell Line,,,,,,iPNF95.6
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line,OLN93 mouse oligodendrocyte cell line,Cell Line,,,,,,OLN93 mouse oligodendrocyte cell line
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.95,cell_line,SC4-immortalized Nf2-/- primary Schwann cells,Cell Line,,,,,,SC4-immortalized Nf2-/- primary Schwann cells
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line,RT4-D6PT2 schwannoma cell line,Cell Line,,,,,,RT4-D6PT2 schwannoma cell line
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line,TC620 human oligodendroglioma cell line,Cell Line,,,,,,TC620 human oligodendroglioma cell line
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.85,cell_line,Normal human Schwann cells (NHSC),Cell Line,,,,,,Normal human Schwann cells (NHSC)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.9,cell_line,MPNST cell lines,Cell Line,,,,,,MPNST cell lines
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line,MPNST 88-14 cells,Cell Line,,,,,,MPNST 88-14 cells
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line,MPNST S462-TY cells,Cell Line,,,,,,MPNST S462-TY cells
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line,S462 cell line,Cell Line,,,,,,S462 cell line
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line,2884 cell line,Cell Line,,,,,,2884 cell line
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line,2885 cell line,Cell Line,,,,,,2885 cell line
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,hTERT NF1 ipn02.3 2λ,Cell Line,,,,,,hTERT NF1 ipn02.3 2λ
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,ipn95.11bC,Cell Line,,,,,,ipn95.11bC
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,sNF96.2,Cell Line,,,,,,sNF96.2
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,MPNST642,Cell Line,,,,,,MPNST642
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,,0.9,animal_model,NF1 flox/− mice,Animal Model,,,,,,NF1 flox/− mice
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,0.9,cell_line,ipn97.4 immortalized human Schwann cells,Cell Line,,,,,,ipn97.4 immortalized human Schwann cells
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.9,cell_line,Schwann cells,Cell Line,,,,,,Schwann cells
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.9,animal_model,Nf1fl/fl mice,Animal Model,,,,,,Nf1fl/fl mice
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.9,animal_model,OPG Nf1fl/mut (Nf1+/−) mice,Animal Model,,,,,,OPG Nf1fl/mut (Nf1+/−) mice
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.8,cell_line,optic glioma cells,Cell Line,,,,,,optic glioma cells
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,0.95,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,HSC1λ,Cell Line,,,,,,HSC1λ
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,ipNF06.2A,Cell Line,,,,,,ipNF06.2A
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,STS-26T,Cell Line,,,,,,STS-26T
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,S462TY,Cell Line,,,,,,S462TY
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,0.9,animal_model,Nf1 flox/flox,Animal Model,,,,,,Nf1 flox/flox
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,0.9,animal_model,Nf1 +/−,Animal Model,,,,,,Nf1 +/−
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,0.9,animal_model,Nf1 +/− GFAP CKO,Animal Model,,,,,,Nf1 +/− GFAP CKO
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.85,cell_line,S462,Cell Line,,,,,,S462
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.85,cell_line,S462-TY,Cell Line,,,,,,S462-TY
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.85,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.85,cell_line,T265,Cell Line,,,,,,T265
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.85,cell_line,STS-26T,Cell Line,,,,,,STS-26T
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,genetic_reagent,Nf1 flox,Genetic Reagent,,,,,,Nf1 flox
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,genetic_reagent,Nf1 KO,Genetic Reagent,,,,,,Nf1 KO
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,animal_model,Nf1 hGFAP CKO,Animal Model,,,,,,Nf1 hGFAP CKO
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,animal_model,Nf1 NcreER CKO,Animal Model,,,,,,Nf1 NcreER CKO
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,0.85,cell_line,HeLa cells,Cell Line,,,,,,HeLa cells
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,0.95,cell_line,S462 cells,Cell Line,,,,,,S462 cells
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,0.85,cell_line,C2C12 cells,Cell Line,,,,,,C2C12 cells
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line,NF1-1 hiPSC line,Cell Line,,,,,,NF1-1 hiPSC line
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line,NF1-2 hiPSC line,Cell Line,,,,,,NF1-2 hiPSC line
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line,WT-1 hiPSC line,Cell Line,,,,,,WT-1 hiPSC line
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line,WT-2 hiPSC line,Cell Line,,,,,,WT-2 hiPSC line
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,cell_line,HEK293T cells,Cell Line,,,,,,HEK293T cells
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,cell_line,HeLa cells,Cell Line,,,,,,HeLa cells
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.85,cell_line,LUVA cells,Cell Line,,,,,,LUVA cells
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,0.95,animal_model,Nf1 flox mice,Animal Model,,,,,,Nf1 flox mice
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,0.95,animal_model,Nf1 fcr mice,Animal Model,,,,,,Nf1 fcr mice
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,0.95,cell_line,sNF96.2,Cell Line,,,,,,sNF96.2
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,0.85,cell_line,HEK293T,Cell Line,,,,,,HEK293T
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.95,cell_line,HEI-193,Cell Line,,,,,,HEI-193
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)",Cell Line,,,,,,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)"
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",Cell Line,,,,,,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)"
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.85,cell_line,HEK-293T,Cell Line,,,,,,HEK-293T
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line,NF37,Cell Line,,,,,,NF37
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line,NF87,Cell Line,,,,,,NF87
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line,CT10,Cell Line,,,,,,CT10
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line,CT11,Cell Line,,,,,,CT11
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line,CT12,Cell Line,,,,,,CT12
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,0.9,animal_model,Dhh-Cre mice,Animal Model,,,,,,Dhh-Cre mice
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,0.95,cell_line,SNF02.2,Cell Line,,,,,,SNF02.2
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,0.95,cell_line,SNF96.2,Cell Line,,,,,,SNF96.2
PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,,0.95,clinical_assessment_tool,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,Clinical Assessment Tool,,,,,,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,0.9,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,0.9,animal_model,Nf1flox/flox mice,Animal Model,,,,,,Nf1flox/flox mice
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,0.95,animal_model,Nf1 ± mice,Animal Model,,,,,,Nf1 ± mice
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,0.95,animal_model,Nf1 flox/flox,Animal Model,,,,,,Nf1 flox/flox
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,0.9,animal_model,hGFAP-Cre,Animal Model,,,,,,hGFAP-Cre
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line,TM-31,Cell Line,,,,,,TM-31
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,cell_line,LN319,Cell Line,,,,,,LN319
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line,17,Cell Line,,,,,,17
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line,5653,Cell Line,,,,,,5653
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line,5746,Cell Line,,,,,,5746
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,advanced_cellular_model,spheroid culture system,Advanced Cellular Model,,,,,,spheroid culture system
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,0.9,cell_line,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",Cell Line,,,,,,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)"
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.85,cell_line,MPNST,Cell Line,,,,,,MPNST
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.9,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line,LS141,Cell Line,,,,,,LS141
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line,DDLS,Cell Line,,,,,,DDLS
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.85,cell_line,Human Schwann cells (HSCs),Cell Line,,,,,,Human Schwann cells (HSCs)
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,cell_line,RT4-D6P2T schwannoma cells,Cell Line,,,,,,RT4-D6P2T schwannoma cells
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,cell_line,HEI-193,Cell Line,,,,,,HEI-193
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,0.85,animal_model,Nf1 mice,Animal Model,,,,,,Nf1 mice
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.85,cell_line,HEK 293T cell line,Cell Line,,,,,,HEK 293T cell line
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.85,cell_line,LN428 human glioblastoma multiforme (GBM) cell line,Cell Line,,,,,,LN428 human glioblastoma multiforme (GBM) cell line
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.95,animal_model,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",Animal Model,,,,,,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO"
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,0.85,cell_line,C2C12,Cell Line,,,,,,C2C12
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,0.9,cell_line,ipNF95.11b C,Cell Line,,,,,,ipNF95.11b C
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,0.9,cell_line,ipNF05.5,Cell Line,,,,,,ipNF05.5
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,0.85,advanced_cellular_model,TAME chips,Advanced Cellular Model,,,,,,TAME chips
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,0.9,cell_line,BL21(DE3) Star,Cell Line,,,,,,BL21(DE3) Star
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,0.9,cell_line,S462-TY,Cell Line,,,,,,S462-TY
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,0.9,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,0.9,cell_line,STS-26T,Cell Line,,,,,,STS-26T
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,0.85,cell_line,NF1-null 293T cells,Cell Line,,,,,,NF1-null 293T cells
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,0.9,cell_line,ipNF95.11b C,Cell Line,,,,,,ipNF95.11b C
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool,Cirrus HD-OCT,Clinical Assessment Tool,,,,,,Cirrus HD-OCT
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool,Teller acuity cards,Clinical Assessment Tool,,,,,,Teller acuity cards
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool,Cardiff acuity cards,Clinical Assessment Tool,,,,,,Cardiff acuity cards
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool,Lea cards,Clinical Assessment Tool,,,,,,Lea cards
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool,KM (Konstantin Moutakis) cards,Clinical Assessment Tool,,,,,,KM (Konstantin Moutakis) cards
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool,Humphrey Field Analyzer perimetry,Clinical Assessment Tool,,,,,,Humphrey Field Analyzer perimetry
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool,World Health Organization Categories of Childhood VI scale,Clinical Assessment Tool,,,,,,World Health Organization Categories of Childhood VI scale
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,0.85,cell_line,Mouse embryonic fibroblasts (MEFs),Cell Line,,,,,,Mouse embryonic fibroblasts (MEFs)
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line,JH-2-002,Cell Line,,,,,,JH-2-002
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line,JH-2-031,Cell Line,,,,,,JH-2-031
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line,JH-2-079c,Cell Line,,,,,,JH-2-079c
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line,JH-2-103,Cell Line,,,,,,JH-2-103
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,JH-2-002 PDX,Patient-Derived Model,,,,,,JH-2-002 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,JH-2-031 PDX,Patient-Derived Model,,,,,,JH-2-031 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,JH-2-079c PDX,Patient-Derived Model,,,,,,JH-2-079c PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,WU-225 PDX,Patient-Derived Model,,,,,,WU-225 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,WU-386 PDX,Patient-Derived Model,,,,,,WU-386 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,WU-545 PDX,Patient-Derived Model,,,,,,WU-545 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,MN-2 PDX,Patient-Derived Model,,,,,,MN-2 PDX
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model,MN-3-002 PDX,Patient-Derived Model,,,,,,MN-3-002 PDX
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,iHSCs,Cell Line,,,,,,iHSCs
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,S462-TY,Cell Line,,,,,,S462-TY
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,0.8,cell_line,K562,Cell Line,,,,,,K562
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line,icNF 97.2a,Cell Line,,,,,,icNF 97.2a
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line,icNF 97.2b,Cell Line,,,,,,icNF 97.2b
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line,icNF 98.4d,Cell Line,,,,,,icNF 98.4d
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.85,cell_line,293T cells,Cell Line,,,,,,293T cells
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.95,cell_line,sNF96.2,Cell Line,,,,,,sNF96.2
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line,HFFs,Cell Line,,,,,,HFFs
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line,NCI-H266,Cell Line,,,,,,NCI-H266
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line,K562,Cell Line,,,,,,K562
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,0.85,cell_line,Neurofibromatosis 1 fibroblasts,Cell Line,,,,,,Neurofibromatosis 1 fibroblasts
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,0.95,animal_model,Postn-Cre; Nf2flox/flox,Animal Model,,,,,,Postn-Cre; Nf2flox/flox
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,0.9,animal_model,Nf2flox/flox,Animal Model,,,,,,Nf2flox/flox
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.85,cell_line,iHSCs,Cell Line,,,,,,iHSCs
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,cell_line,S462-TY,Cell Line,,,,,,S462-TY
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.85,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,animal_model,"Dhh::Cre, Nf1fl/fl, Pten",Animal Model,,,,,,"Dhh::Cre, Nf1fl/fl, Pten"
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,patient_derived_model,Patient-derived xenograft (PDX) MPNST model,Patient-Derived Model,,,,,,Patient-derived xenograft (PDX) MPNST model
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,0.9,animal_model,Nf1^flox/flox;GFAP-Cre mice,Animal Model,,,,,,Nf1^flox/flox;GFAP-Cre mice
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line,MPNST-SP-01,Cell Line,,,,,,MPNST-SP-01
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line,MPNST-NF1-08,Cell Line,,,,,,MPNST-NF1-08
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line,MPNST-NF1-9,Cell Line,,,,,,MPNST-NF1-9
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,STS-26T,Cell Line,,,,,,STS-26T
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,HS-PSS,Cell Line,,,,,,HS-PSS
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,HS-sch2,Cell Line,,,,,,HS-sch2
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,S462,Cell Line,,,,,,S462
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line,sNF96.2,Cell Line,,,,,,sNF96.2
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.8,cell_line,Human Foreskin Fibroblast (HFF),Cell Line,,,,,,Human Foreskin Fibroblast (HFF)
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,MPNST-SP-01 PDOX,Patient-Derived Model,,,,,,MPNST-SP-01 PDOX
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,MPNST-NF1-09 PDOX,Patient-Derived Model,,,,,,MPNST-NF1-09 PDOX
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,0.95,animal_model,DhhCre;Nf1fl/fl,Animal Model,,,,,,DhhCre;Nf1fl/fl
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.9,cell_line,ipNF95.11b C,Cell Line,,,,,,ipNF95.11b C
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.9,cell_line,ipNF95.11b C-RFP,Cell Line,,,,,,ipNF95.11b C-RFP
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.9,cell_line,ipNF 05.5,Cell Line,,,,,,ipNF 05.5
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.85,advanced_cellular_model,3D rBM overlay model,Advanced Cellular Model,,,,,,3D rBM overlay model
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,0.9,patient_derived_model,vestibular schwannoma xenografts,Patient-Derived Model,,,,,,vestibular schwannoma xenografts
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,cell_line,Ben-Men-1,Cell Line,,,,,,Ben-Men-1
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,cell_line,AC007-hTERT,Cell Line,,,,,,AC007-hTERT
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.85,cell_line,AC028,Cell Line,,,,,,AC028
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.8,cell_line,293T,Cell Line,,,,,,293T
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,0.85,clinical_assessment_tool,Likert scale questionnaire,Clinical Assessment Tool,,,,,,Likert scale questionnaire
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.95,cell_line,U87-MG,Cell Line,,,,,,U87-MG
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.85,cell_line,HEK293T,Cell Line,,,,,,HEK293T
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line,Meso-33,Cell Line,,,,,,Meso-33
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line,FC-1801,Cell Line,,,,,,FC-1801
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.85,cell_line,293T,Cell Line,,,,,,293T
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.9,cell_line,NIH-3T3,Cell Line,,,,,,NIH-3T3
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.85,cell_line,φNX packaging cell line,Cell Line,,,,,,φNX packaging cell line
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,H1838,Cell Line,,,,,,H1838
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,WM3918,Cell Line,,,,,,WM3918
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,M308,Cell Line,,,,,,M308
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,NF90.8,Cell Line,,,,,,NF90.8
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,NF94.3,Cell Line,,,,,,NF94.3
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,NF96.2,Cell Line,,,,,,NF96.2
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,NF10.1,Cell Line,,,,,,NF10.1
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line,NF11.1,Cell Line,,,,,,NF11.1
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–002,Patient-Derived Model,,,,,,JH-2–002
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–009,Patient-Derived Model,,,,,,JH-2–009
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–031,Patient-Derived Model,,,,,,JH-2–031
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–055,Patient-Derived Model,,,,,,JH-2–055
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–060,Patient-Derived Model,,,,,,JH-2–060
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–074,Patient-Derived Model,,,,,,JH-2–074
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,JH-2–077,Patient-Derived Model,,,,,,JH-2–077
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model,PDX JH-2–002,Patient-Derived Model,,,,,,PDX JH-2–002
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,0.95,animal_model,Nf1Prx1,Animal Model,,,,,,Nf1Prx1
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,0.95,animal_model,Nf1Col1,Animal Model,,,,,,Nf1Col1
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,0.9,animal_model,Stat3(fl/fl);Nf1(fl/fl);DhhCre,Animal Model,,,,,,Stat3(fl/fl);Nf1(fl/fl);DhhCre
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,0.85,genetic_reagent,NF2 TET,Genetic Reagent,,,,,,NF2 TET
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model,Nf1f/f;Trp53f/f;Nes-TK,Animal Model,,,,,,Nf1f/f;Trp53f/f;Nes-TK
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model,Nf1f/f;Trp53f/f;CGD,Animal Model,,,,,,Nf1f/f;Trp53f/f;CGD
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.85,animal_model,cisNP,Animal Model,,,,,,cisNP
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,0.9,animal_model,Nf1-/- mice,Animal Model,,,,,,Nf1-/- mice
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,0.9,cell_line,K4622 grade II glioma cell line,Cell Line,,,,,,K4622 grade II glioma cell line
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line,HSR-GBM1,Cell Line,,,,,,HSR-GBM1
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line,JHH-520,Cell Line,,,,,,JHH-520
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line,JHU-0879,Cell Line,,,,,,JHU-0879
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line,JHU-1016B,Cell Line,,,,,,JHU-1016B
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line,JHH-136,Cell Line,,,,,,JHH-136
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line,B76,Cell Line,,,,,,B76
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line,NGT-41,Cell Line,,,,,,NGT-41
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line,NMCG-1,Cell Line,,,,,,NMCG-1
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line,DBTRG,Cell Line,,,,,,DBTRG
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.8,cell_line,LN229,Cell Line,,,,,,LN229
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.8,cell_line,T98G,Cell Line,,,,,,T98G
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,,0.9,cell_line,U251,Cell Line,,,,,,U251
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.9,cell_line,U251,Cell Line,,,,,,U251
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.9,cell_line,MiaPaCa-2,Cell Line,,,,,,MiaPaCa-2
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.9,cell_line,PANC1,Cell Line,,,,,,PANC1
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.9,cell_line,BxPc3,Cell Line,,,,,,BxPc3
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.95,cell_line,ipNF95.6,Cell Line,,,,,,ipNF95.6
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,0.85,cell_line,HEK 293T,Cell Line,,,,,,HEK 293T
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,0.85,cell_line,PNF-derived Schwann cells,Cell Line,,,,,,PNF-derived Schwann cells
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,0.9,animal_model,Nf1flox/flox,Animal Model,,,,,,Nf1flox/flox
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.95,cell_line,JHH-520 cell line,Cell Line,,,,,,JHH-520 cell line
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line,GBM1 cell line,Cell Line,,,,,,GBM1 cell line
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line,JHH-0879 cell line,Cell Line,,,,,,JHH-0879 cell line
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,0.95,animal_model,Nf1fl/fl;DhhCre,Animal Model,,,,,,Nf1fl/fl;DhhCre
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,0.95,animal_model,Nf1flox/flox,Animal Model,,,,,,Nf1flox/flox
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,0.95,animal_model,Nf1+/−,Animal Model,,,,,,Nf1+/−
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.95,clinical_assessment_tool,BoN (Burden of NF1) questionnaire,Clinical Assessment Tool,,,,,,BoN (Burden of NF1) questionnaire
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool,Dermatology Life Quality Index (DLQI),Clinical Assessment Tool,,,,,,Dermatology Life Quality Index (DLQI)
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool,SF12,Clinical Assessment Tool,,,,,,SF12
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,S520,Cell Line,,,,,,S520
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,88-3,Cell Line,,,,,,88-3
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,90-8,Cell Line,,,,,,90-8
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line,YST1,Cell Line,,,,,,YST1
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF97.2a,Cell Line,,,,,,icNF97.2a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF97.2b,Cell Line,,,,,,icNF97.2b
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF98.4c,Cell Line,,,,,,icNF98.4c
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF98.4d,Cell Line,,,,,,icNF98.4d
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF00.10a,Cell Line,,,,,,icNF00.10a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,icNF04.9a,Cell Line,,,,,,icNF04.9a
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,i28cNF,Cell Line,,,,,,i28cNF
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,i18cNF,Cell Line,,,,,,i18cNF
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line,i21cNF,Cell Line,,,,,,i21cNF
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,0.9,cell_line,cisMPNST cells,Cell Line,,,,,,cisMPNST cells
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,sNF96.2,Cell Line,,,,,,sNF96.2
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,90-8,Cell Line,,,,,,90-8
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,STS-26T,Cell Line,,,,,,STS-26T
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,HS-Sch-2,Cell Line,,,,,,HS-Sch-2
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line,CCD-1112Sk,Cell Line,,,,,,CCD-1112Sk
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.85,cell_line,Rosetta2(DE3) competent cells,Cell Line,,,,,,Rosetta2(DE3) competent cells
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,0.9,animal_model,Nf2 flox2/flox2 mice,Animal Model,,,,,,Nf2 flox2/flox2 mice
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,0.95,animal_model,Nf2 flox2/flox2 ;p16 Ink4a*/* mice,Animal Model,,,,,,Nf2 flox2/flox2 ;p16 Ink4a*/* mice
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,ST88-3,Cell Line,,,,,,ST88-3
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,T265p21,Cell Line,,,,,,T265p21
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,S520,Cell Line,,,,,,S520
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,90-8,Cell Line,,,,,,90-8
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,YST1,Cell Line,,,,,,YST1
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line,DS-red STS26T cell line,Cell Line,,,,,,DS-red STS26T cell line
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.9,animal_model,H7;Nf1mut mice,Animal Model,,,,,,H7;Nf1mut mice
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.95,cell_line,hTERT ipNF05.5,Cell Line,,,,,,hTERT ipNF05.5
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.9,cell_line,hTERT ipn02.3 2λ,Cell Line,,,,,,hTERT ipn02.3 2λ
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.8,cell_line,E13.5 DRG neurosphere cells,Cell Line,,,,,,E13.5 DRG neurosphere cells
PMID:38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,0.95,clinical_assessment_tool,PlexiQoL,Clinical Assessment Tool,,,,,,PlexiQoL
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.9,animal_model,Nf1^flox/flox;GFAP-Cre,Animal Model,,,,,,Nf1^flox/flox;GFAP-Cre
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.9,animal_model,Nf1^flox/mut;GFAP-Cre,Animal Model,,,,,,Nf1^flox/mut;GFAP-Cre
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.85,cell_line,Daoy,Cell Line,,,,,,Daoy
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,0.85,cell_line,NF1-/- iPSC-derived neural crest cells,Cell Line,,,,,,NF1-/- iPSC-derived neural crest cells
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model,DhhCre mice,Animal Model,,,,,,DhhCre mice
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model,Nf1flox/flox;PostnCre+ mice,Animal Model,,,,,,Nf1flox/flox;PostnCre+ mice
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model,Nf1flox/flox;Arf flox/flox;PostnCre+ mice,Animal Model,,,,,,Nf1flox/flox;Arf flox/flox;PostnCre+ mice
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line,JH-2-002 cell line,Cell Line,,,,,,JH-2-002 cell line
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line,JH-2-103 cell line,Cell Line,,,,,,JH-2-103 cell line
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line,ST-8814 cell line,Cell Line,,,,,,ST-8814 cell line
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line,S462 cell line,Cell Line,,,,,,S462 cell line
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,cell_line,hTERT ipn02.3 2λ cell line,Cell Line,,,,,,hTERT ipn02.3 2λ cell line
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,cell_line,hTERT NF1 ipNF95.6 cell line,Cell Line,,,,,,hTERT NF1 ipNF95.6 cell line
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1+/− mice,Animal Model,,,,,,Nf1+/− mice
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1flox/wt mice,Animal Model,,,,,,Nf1flox/wt mice
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1flox/mut mice,Animal Model,,,,,,Nf1flox/mut mice
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1flox/flox; Olig2-Cre mice,Animal Model,,,,,,Nf1flox/flox; Olig2-Cre mice
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1flox/flox mice,Animal Model,,,,,,Nf1flox/flox mice
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model,Nf1flox/flox; Prom1-CreER mice,Animal Model,,,,,,Nf1flox/flox; Prom1-CreER mice
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,0.95,animal_model,Nf1flox/flox;PostnCre+ mice,Animal Model,,,,,,Nf1flox/flox;PostnCre+ mice
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.9,cell_line,M1,Cell Line,,,,,,M1
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.9,cell_line,M3,Cell Line,,,,,,M3
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.9,cell_line,M4,Cell Line,,,,,,M4
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.9,cell_line,M6,Cell Line,,,,,,M6
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line,"HEK-293T cells (ATCC; cat. #CRL-3216, RRID:CVCL_0063)",Cell Line,,,,,,"HEK-293T cells (ATCC; cat. #CRL-3216, RRID:CVCL_0063)"
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line,ipnNF95.11C,Cell Line,,,,,,ipnNF95.11C
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line,ipNF05.5-MX,Cell Line,,,,,,ipNF05.5-MX
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line,ipNF06.2A,Cell Line,,,,,,ipNF06.2A
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line,ipNF95.11b C/T,Cell Line,,,,,,ipNF95.11b C/T
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line,ipNF95.6,Cell Line,,,,,,ipNF95.6
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line,ipNF02.3 2λ,Cell Line,,,,,,ipNF02.3 2λ
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line,ipNF02.8,Cell Line,,,,,,ipNF02.8
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,0.95,computational_tool,RENOVO-NF1,Computational Tool,,,,,,RENOVO-NF1
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,0.95,animal_model,Nf1 fl/+,Animal Model,,,,,,Nf1 fl/+
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.95,advanced_cellular_model,cNF organoids,Advanced Cellular Model,,,,,,cNF organoids
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.9,patient_derived_model,Cutaneous neurofibroma samples,Patient-Derived Model,,,,,,Cutaneous neurofibroma samples
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,NF95.11b,Cell Line,,,,,,NF95.11b
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,NF95.6,Cell Line,,,,,,NF95.6
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,SNF02.2,Cell Line,,,,,,SNF02.2
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,SNF94.3,Cell Line,,,,,,SNF94.3
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,SNF96.2,Cell Line,,,,,,SNF96.2
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line,JW18.2,Cell Line,,,,,,JW18.2
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line,JW23.3,Cell Line,,,,,,JW23.3
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model,Periostin-CRE;NF2 fl/fl,Animal Model,,,,,,Periostin-CRE;NF2 fl/fl
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,animal_model,P0-CRE,Animal Model,,,,,,P0-CRE
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line,BenMen-1,Cell Line,,,,,,BenMen-1
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line,KT21-MG1,Cell Line,,,,,,KT21-MG1
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,cell_line,293FT,Cell Line,,,,,,293FT
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,cell_line,U251,Cell Line,,,,,,U251
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,0.95,cell_line,HeLa cells,Cell Line,,,,,,HeLa cells
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,0.9,cell_line,NF2 primary fibroblasts,Cell Line,,,,,,NF2 primary fibroblasts
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.95,animal_model,Postn-cre;Nf2f/f,Animal Model,,,,,,Postn-cre;Nf2f/f
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.9,cell_line,Primary human vestibular schwannoma (VS) cell cultures,Cell Line,,,,,,Primary human vestibular schwannoma (VS) cell cultures
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.95,cell_line,NF90-8,Cell Line,,,,,,NF90-8
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.85,cell_line,Primary normal rat Schwann cells,Cell Line,,,,,,Primary normal rat Schwann cells
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.85,cell_line,iSC,Cell Line,,,,,,iSC
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line,ipNF95.11bC,Cell Line,,,,,,ipNF95.11bC
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line,ipnNF95.11c,Cell Line,,,,,,ipnNF95.11c
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line,ipNF05.5 Single Clone,Cell Line,,,,,,ipNF05.5 Single Clone
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line,ipNF05.5 Mixed Clones,Cell Line,,,,,,ipNF05.5 Mixed Clones
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.85,animal_model,DhhCre;Nf1f/f;Luciferase,Animal Model,,,,,,DhhCre;Nf1f/f;Luciferase
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,0.9,patient_derived_model,human neurofibroma xenografts,Patient-Derived Model,,,,,,human neurofibroma xenografts
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,0.95,animal_model,Nf1+/− GFAP CKO mice,Animal Model,,,,,,Nf1+/− GFAP CKO mice
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,0.9,animal_model,Nf1 flox/flox mice,Animal Model,,,,,,Nf1 flox/flox mice
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,0.95,animal_model,Tg(U6x:nf2a/b-4sgRNA),Animal Model,,,,,,Tg(U6x:nf2a/b-4sgRNA)
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model,Osx-/- Nf1flox/flox mice,Animal Model,,,,,,Osx-/- Nf1flox/flox mice
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model,"Osx-tTA,tetO-cre;Nf1flox/flox mice",Animal Model,,,,,,"Osx-tTA,tetO-cre;Nf1flox/flox mice"
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.8,cell_line,Nf1flox/flox bone marrow stromal cells,Cell Line,,,,,,Nf1flox/flox bone marrow stromal cells
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,0.85,animal_model,Nf2 mice,Animal Model,,,,,,Nf2 mice
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,0.8,cell_line,DH5α bacteria,Cell Line,,,,,,DH5α bacteria
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,0.95,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,0.9,cell_line,mouse embryonic fibroblasts (MEFs),Cell Line,,,,,,mouse embryonic fibroblasts (MEFs)
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,0.9,cell_line,tail-tip fibroblasts (TTFs),Cell Line,,,,,,tail-tip fibroblasts (TTFs)
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,0.9,animal_model,Nf1+/- mice,Animal Model,,,,,,Nf1+/- mice
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.8,cell_line,Neural stem cells,Cell Line,,,,,,Neural stem cells
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,0.9,animal_model,Nf2flox/flox mice,Animal Model,,,,,,Nf2flox/flox mice
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,0.9,cell_line,Nf2-deficient spinal cord neural progenitor cells,Cell Line,,,,,,Nf2-deficient spinal cord neural progenitor cells
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model,Nf1 flox/flox mice,Animal Model,,,,,,Nf1 flox/flox mice
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,0.85,cell_line,MCF7,Cell Line,,,,,,MCF7
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.9,cell_line,NSF1,Cell Line,,,,,,NSF1
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.8,cell_line,BRGN,Cell Line,,,,,,BRGN
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.85,cell_line,primary human Schwann cells (HSC),Cell Line,,,,,,primary human Schwann cells (HSC)
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,0.95,animal_model,Nf1 (+/-),Animal Model,,,,,,Nf1 (+/-)
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.9,cell_line,S462TY,Cell Line,,,,,,S462TY
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.9,cell_line,ST8814,Cell Line,,,,,,ST8814
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.85,cell_line,Normal human Schwann cells (HSC),Cell Line,,,,,,Normal human Schwann cells (HSC)
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.9,cell_line,T265,Cell Line,,,,,,T265
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.9,cell_line,NSF1,Cell Line,,,,,,NSF1
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.85,cell_line,B8 fibroblasts,Cell Line,,,,,,B8 fibroblasts
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,0.9,cell_line,STS26T,Cell Line,,,,,,STS26T
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,0.9,cell_line,S462,Cell Line,,,,,,S462
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line,ipNF05.5,Cell Line,,,,,,ipNF05.5
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line,95.6,Cell Line,,,,,,95.6
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line,ipn02.3,Cell Line,,,,,,ipn02.3
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.95,cell_line,ST88-14,Cell Line,,,,,,ST88-14
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.95,cell_line,S462,Cell Line,,,,,,S462
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.95,cell_line,NF90-8,Cell Line,,,,,,NF90-8
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,patient_derived_model,RHT-92,Patient-Derived Model,,,,,,RHT-92
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,animal_model,Nf1 flox/flox-;Postn-Cre,Animal Model,,,,,,Nf1 flox/flox-;Postn-Cre
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,animal_model,Nf1-Arf flox/flox ;Postn-Cre,Animal Model,,,,,,Nf1-Arf flox/flox ;Postn-Cre
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,,0.95,clinical_assessment_tool,PlexiQoL,Clinical Assessment Tool,,,,,,PlexiQoL
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,0.9,animal_model,Nf2 flox2/flox2 mice,Animal Model,,,,,,Nf2 flox2/flox2 mice
